JAC Advance Access originally published online on September 6, 2005
Journal of Antimicrobial Chemotherapy 2005 56(4):609-610; doi:10.1093/jac/dki313
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Editorial |
Conflicts of interest/transparency declarations: new policy
JAC Editorial Office, 11 The Wharf, 16 Bridge Street, Birmingham B1 2JS, UK
* Corresponding author. Tel: +44-121-633-0415; Fax: +44-121-643-9497; E-mail: jac@bsac.org.uk
| The first 10% of the full text of this article appears below. |
Introduction
We believe that it is important for readers of JAC to be made aware of any interests of authors that could be perceived as having influenced the views they have expressed. Only when appropriately informed can readers make a judgment regarding the potential for interests to influence a particular article.
There are many journals that stipulate that authors declare their conflicts of interest. Indeed, for some time our Instructions to Authors have stated that any conflicting interests should be disclosed. However, although increasing numbers of authors have been providing this information, not all authors have done so, and it is not something that we have either strictly enforced or provided
Funding
What should be included in the transparency declarations?
Editor-in-Chief, Editors and Referees
Time frame
Summary